Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B

HighlightsApproximately 20% of patients with CHB who have just achieved HBsAg loss under IFNα treatment show positive serum HBV DNA and/or HBeAg.During disease progression, in frame indel mutations accumulate in the HBV genome's SP1 and SP2 promoters, with epigenetic modifications contributing to their suppression.In frame indel mutations in the HBV genome's SP1 and SP2 promoters inhibit the transcription of HBV S mRNA and promote the transcription of 3.5 kb HBV RNA.The loss of L-HBs and envelop proteins leads to an increase in intracellular cccDNA, promoting the maintenance of chronic infection.

Authors

Institutions

Publication Details

Journal
Emerging Microbes & Infections
Published
2025-03-04
DOI
https://doi.org/10.1080/22221751.2025.2475847
Citations
6
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
8.13

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B

Bei Jiang, Yuchen Xia, Yifei Guo, Kaitao Zhao et al.
6 citations
Emerging Microbes & Infections
Hepatitis B Virus Studies
8.13
article

Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B

Bei Jiang, Yuchen Xia, Yifei Guo, Kaitao Zhao, Man‐Fung Yuen, Lin Wang, Fengmin Lu, Minghui Li, Weilin Gu, Jiming Zhang, Zhiqiang Gu, Zhenhuan Cao, Guiwen Guan, Xiangmei Chen
article en
6 citations

Abstract

HighlightsApproximately 20% of patients with CHB who have just achieved HBsAg loss under IFNα treatment show positive serum HBV DNA and/or HBeAg.During disease progression, in frame indel mutations accumulate in the HBV genome's SP1 and SP2 promoters, with epigenetic modifications contributing to their suppression.In frame indel mutations in the HBV genome's SP1 and SP2 promoters inhibit the transcription of HBV S mRNA and promote the transcription of 3.5 kb HBV RNA.The loss of L-HBs and envelop proteins leads to an increase in intracellular cccDNA, promoting the maintenance of chronic infection.

Emerging Microbes & InfectionsVol. 14(1)
Shanghai Medical College of Fudan University (CN), Capital University (US), Capital Medical University (CN), Peking University (CN), Fudan University (CN), Queen Mary Hospital (CN), Wuhan University (CN), Wuhan Institute of Virology (CN), Tianjin People's Hospital (CN), Xian Yang Central Hospital (CN), Beijing YouAn Hospital (CN), Taishan Medical University (CN), Huashan Hospital (CN), Shenzhen Blood Center (CN), Institute of Virology of the Slovak Academy of Sciences (SK), State Key Laboratory of Virology, University of Hong Kong (HK)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 3%
Hepatitis B Virus Studies
8.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.